PEG-PPG-PEG Gel Adhesion for Anti-adhesion and Biocompatibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-adhesion agents for preventing surgical adhesions lack effective adhesive properties, are not biocompatible, and fail to maintain their anti-adhesive function over the necessary wound healing period, especially in minimally invasive and laparoscopic surgeries.
Innovation Solution
An anti-adhesion polymer composition comprising 24-50 wt% PEG-PPG-PEG block copolymer, 0.03-5 wt% gelatin, and 3 wt% chitosan, which forms a gel at body temperature to adhere to wound sites, inhibit adhesion, and exhibit antibacterial and hemostatic properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural polymers like cellulose or dextran are used as anti-adhesion agents, then biocompatibility is improved, but foreign body reactions occur because they are not derived from living bodies and cause inflammatory responses
Solution Approach 1:
The patent uses a composite material system comprising gelatin (a natural polymer derived from living bodies) combined with PEG-PPG-PEG block copolymer and chitosan. This composite approach leverages the biocompatibility of gelatin while incorporating synthetic components to enhance functional properties, thereby resolving the contradiction between natural origin and biocompatibility.
Solution Approach 2:
The patent modifies the molecular weight parameters of the PEG-PPG-PEG block copolymer (specifically using poloxamer 407 with defined molecular characteristics) to optimize the balance between biocompatibility and functional performance. By carefully selecting molecular weight parameters, the composition achieves reduced foreign body reactions while maintaining effective anti-adhesion properties.
2Strength
If synthetic polymers like poly(lactic acid) are used, then adhesive properties are improved, but inflammatory reactions occur due to acidic degradation products
Solution Approach 1:
The patent introduces gelatin as an intermediary substance that mediates between the synthetic PEG-PPG-PEG block copolymer and the biological environment. Gelatin provides natural biocompatibility and reduces inflammatory responses while maintaining the adhesive properties contributed by the synthetic polymer components.
Solution Approach 2:
The patent carefully controls the molecular weight and composition parameters of the PEG-PPG-PEG block copolymer to optimize adhesive properties while minimizing the generation of harmful acidic degradation products. By adjusting these parameters, the composition achieves effective adhesion with reduced inflammatory potential.
3Reliability
If hyaluronic acid is used as anti-adhesion agent, then biocompatibility is improved, but anti-adhesion function is limited due to short in vivo half-life of only 3 days
Solution Approach 1:
The patent creates a composite system where gelatin and PEG-PPG-PEG block copolymer work synergistically to extend the duration of action. The combination provides sustained release and prolonged residence time at the wound site, overcoming the short half-life limitation of hyaluronic acid while maintaining biocompatibility.
Solution Approach 2:
The patent designs a multi-functional composition that simultaneously provides anti-adhesion, antibacterial, and hemostatic properties. This multi-functionality extends the effective duration of action by addressing multiple aspects of wound healing concurrently, thereby compensating for the limited half-life of individual components.
4Reliability
If anti-adhesion barrier is applied to prevent tissue adhesion, then adhesion prevention is improved, but the material must be degraded naturally or removed after specific period, requiring careful selection of degradable components
Solution Approach 1:
The patent optimizes the molecular weight parameters of the PEG-PPG-PEG block copolymer and the composition ratios of gelatin, chitosan, and PEG-PPG-PEG to control degradation rate. By adjusting these parameters, the composition maintains effective anti-adhesion function for the required duration while ensuring safe and controlled natural degradation.
Solution Approach 2:
The patent designs a self-degrading system where the composition naturally degrades through physiological processes without requiring surgical removal. The gelatin, chitosan, and PEG-PPG-PEG components are selected to degrade via enzymatic and hydrolytic pathways naturally present in the body, providing self-service degradation that simplifies the overall process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively prevents surgical adhesions, maintains strong adhesion to the wound site, and demonstrates enhanced biocompatibility, reducing inflammatory and foreign body reactions, while providing antibacterial and hemostatic benefits.
Implementation Method 1
a polyethyleneglycol-polypropyleneglycol-polyethyleneglycol (PEG-PPG-PEG) block copolymer having a polyethyleneglycol (PEG) content of 65-85 wt% and a molecular weight of 6,000-20,000 Da; which forms a gel at body temperature
Implementation Method 2
has an excellent adhesive property so as to be able to easily and continuously adhere to a wound site
Implementation Method 3
has antibacterial and hemostatic properties
Implementation Method 4
has antibacterial and hemostatic properties
Data Source
Figure 1
AI summary
The present invention relates to an anti-adhesion polymer composition capable of supporting growth factor, which effectively exhibits anti-adhesion function and, at the same time, has an excellent adhesive property so as to be able to easily and continuously adhere to a wound site, has antibacterial and hemostatic properties, and is composed of an injectable formulation suitable for use in minimally invasive surgery, laparoscopic surgery or the like. The anti-adhesion polymer composition capable of supporting growth factor comprises: 24-50 wt% of a polyethyleneglycol-polypropyleneglycol-polyethyleneglycol (PEG-PPG-PEG) block copolymer having a polyethyleneglycol (PEG) content of 65-85 wt% and a molecular weight of 6,000-20,000 Da; 0.03-5 wt% of gelatin; 0.03-5 wt% of chitosan; and distilled water.